(S (NP-SBJ (NP (NN Dimerization)) (PP (IN of) (NP (NN NF-KB2))) (PP (IN with) (NP (NN RelA-LRB-p65-RRB-)))) (VP (VBZ regulates) (NP-COOD (NP (NN DNA) (NN binding)) (, ,) (NP (JJ transcriptional) (NN activation)) (, ,) (CC and) (NP (NN inhibition))) (PP (IN by) (NP (NP (DT an) (NN I) (NN kappa) (NN B-alpha)) (PRN (-LRB- -LRB-) (NP (NN MAD-3)) (-RRB- -RRB-))))) (. .))
(S (NP-SBJ-47 (NP (JJ Inducible) (NN expression)) (PP (IN of) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN regulated) (NP (-NONE- *-47)) (PP (IN by) (NP-LGS (NP (DT a) (JJ cellular) (NN transcription) (NN factor)) (, ,) (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))))))) (. .))
(S (S (NP-SBJ-48 (NN NF-kappa) (NN B)) (VP (VBZ is) (VP (VBN composed) (NP (-NONE- *-48)) (PP (IN of) (NP (JJ distinct) (NNS subunits)))))) (: ;) (S (NP-SBJ-49 (NP (NP (CD five) (JJ independent) (NNS genes)) (, ,) (NP-COOD (NP (NN NFKB1-LRB-p105-RRB-)) (, ,) (NP (NN NFKB2-LRB-p100-RRB-)) (, ,) (NP (NN RelA-LRB-p65-RRB-)) (, ,) (NP (NN c-rel)) (CC and) (NP (NN relB))) (, ,)) (SBAR (WHNP-50 (WDT that)) (S (NP-SBJ (-NONE- *T*-50)) (VP (VBP encode) (NP (NP (JJ related) (NNS proteins)) (SBAR (WHNP-51 (WDT that)) (S (NP-SBJ (-NONE- *T*-51)) (VP (VBP bind) (PP (TO to) (NP (NN kappa) (NN B) (NN DNA) (NNS elements))))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN isolated) (NP (-NONE- *-49)))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (ADVP-TMP (RB previously)) (VBN found) (SBAR (IN that) (S (NP-SBJ-52 (NN (p52-RRB- NFKB2-LRB-p49))) (VP (VBZ acts) (PP (IN in) (NN concert) (IN with) (NP (NN RelA-LRB-p65-RRB-))) (S (NP-SBJ (-NONE- *-52)) (VP (TO to) (VP (VB stimulate) (NP (NP (DT the) (NN HIV) (NN enhancer)) (PP (IN in) (NP (ADJP (NN Jurkat) (NN T-leukemia)) (NNS cells)))))))))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP examine) (NP (NP (DT the) (JJ biochemical) (NN basis)) (PP (IN for) (NP (NP (DT the) (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (NN HIV))) (PP (IN by) (NP (NN NFKB2))))))) (. .))
(S (S (NP-SBJ (-NONE- *-53)) (VP (VBG Using) (NP (NN Scatchard) (NN analysis)))) (, ,) (NP-SBJ-53 (PRP we)) (VP (VBP have) (VP (VBN determined) (NP (NP (DT the) (NN dissociation) (NNS constants)) (PP (IN of) (NP-COOD (NP (JJ homodimeric) (NN p49)) (CC and) (NP (JJ heterodimeric) (NN (p65 p49))))) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (NN binding) (PP (TO to) (NP (DT the) (NN HIV) (NN kappa) (NN B) (NN site))))))))) (. .))
(S (NP-SBJ (NN p49)) (VP (VBZ has) (NP (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 18-fold-lower)) (NN affinity)) (PP (IN for) (NP (DT the) (NN HIV) (NN kappa) (NN B) (NN site)))) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN KD)) (VP (JJ =) (NP-PRD (CD 69.1) (NN pM)))) (-RRB- -RRB-))) (SBAR (IN than) (SINV (VBZ does) (NP-SBJ (NP (DT the) (ADJP (RB approximately) (JJ 50-kDa)) (NN protein) (NP (NP (NN NFKB1-LRB-p50-RRB-))) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NN p105))))) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN KD)) (VP (JJ =) (NP-PRD (CD 3.9) (NN pM)))) (-RRB- -RRB-))) (VP (-NONE- *?*)))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (DT the) (NN affinity)) (PP (IN of) (NP (JJ heterodimeric) (NN (RelA-LRB-p65-RRB- NFKB2-LRB-p49-RRB-)))) (PP (IN for) (NP (DT this) (NN site)))) (VP (VBZ is) (ADJP-PRD (ADJP (ADJP (RB approximately) (RB 6-fold) (JJR higher)) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN KD)) (VP (JJ =) (NP-PRD (CD 11.8) (NN pM)))) (-RRB- -RRB-))) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NN p49))) (ADVP (RB alone)))))) (. .))
(S (S (NP-SBJ (-NONE- *-106)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (DT these) (NNS findings))))) (, ,) (NP-SBJ-54 (ADJP (FW in) (FW vitro)) (NN transcription)) (VP (VBD was) (VP (VBN stimulated) (NP-106 (-NONE- *-54)) (ADVP (RB 18-fold)) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (ADJP-COOD (ADJP (JJ preformed)) (, ,) (ADJP (JJ heterodimeric))) (NN (RelA-LRB-p65-RRB- NFKB2-LRB-p49-RRB-)) (NN protein))))))) (. .))
(S (NP-SBJ (NP (JJ Transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (NN HIV) (NN enhancer)))) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (JJ subject) (PP (TO to) (NP (NP (NN regulation)) (PP (IN by) (NP (ADJP (RB recently) (VBN cloned)) (NP (NP (NN I) (NN kappa) (NN B-alpha)) (PRN (-LRB- -LRB-) (NP (NN MAD-3)) (-RRB- -RRB-))))))))) (. .))
(S (NP-SBJ (JJ Recombinant) (NP (NP (NN I) (NN kappa) (NN B-alpha)) (PRN (-LRB- -LRB-) (NP (NN MAD-3)) (-RRB- -RRB-)))) (VP-COOD (VP (VBD inhibited) (NP (NP (DT the) (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP-COOD (NP (NN p65)) (, ,) (NP (NN (p65 p49))) (, ,) (CC and) (NP (NN (p65 p50))))))) (CC but) (VP (VBD stimulated) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP-COOD (NP (NN NFKB2-LRB-p49-RRB-)) (CC or) (NP (NN NFKB1-LRB-p50-RRB-))))))) (. .))
(S (NP-SBJ-55 (NP (JJ Functional) (NN activation)) (PP (IN of) (NP (DT an) (NN HIV) (NN reporter) (NN plasmid))) (PP (IN by) (NP (NN (p65 p49)))) (PP (IN in) (NP (ADJP (RB transiently) (VBN transfected)) (ADJP (NN Jurkat) (JJ T-leukemia)) (NNS cells)))) (VP (VBD was) (VP (ADVP (RB also)) (VBN inhibited) (NP (-NONE- *-55)) (PP (IN by) (NP-LGS (NP (NN coexpression)) (PP (IN of) (NP (NN MAD-3))))))) (. .))
(S (-LRB- -LRB-) (NP-SBJ-107 (NN ABSTRACT)) (VP (VBN TRUNCATED) (NP (-NONE- *-107)) (PP (IN AT) (NP (CD 250) (NNS WORDS)))) (-RRB- -RRB-))
